GENENTECH, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1976-01-01
- Employees
- 11.1K
- Market Cap
- -
- Website
- http://www.gene.com
A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2016-07-18
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT01986166
A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2013-11-11
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT01980953
- Locations
- 🇺🇸
Covance Research Unit - Dallas, Dallas, Texas, United States
A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model
- Conditions
- Interventions
- First Posted Date
- 2013-11-11
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 101
- Registration Number
- NCT01980966
- Locations
- 🇬🇧
Retroscreen Ltd, London, United Kingdom
A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers
- First Posted Date
- 2013-10-23
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01967966
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
- First Posted Date
- 2013-09-02
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT01933334
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Northwestern University, Chicago, Chicago, Illinois, United States
A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants
- First Posted Date
- 2013-08-28
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01929876
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
- Conditions
- Interventions
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2017-07-06
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01911598
- Locations
- 🇺🇸
University of Chicago; Hematology/Oncology, Chicago, Illinois, United States
🇺🇸University of Colorado Cancer Center Department of Hematology, Aurora, Colorado, United States
🇧🇪Cliniques Universitaires St-Luc, Bruxelles, Belgium
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT01896531
- Locations
- 🇺🇸
Univ of Calif, Los Angeles; Hematology/Oncology, Los Angeles, California, United States
🇺🇸Massachusetts General Hospital;Oncology, Boston, Massachusetts, United States
🇮🇹Azienda Ospedaliero Universitaria Pisana; Uff. Sperim. Clin. U.O. Farmaceutica, Pisa, Toscana, Italy
A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers
- First Posted Date
- 2013-06-14
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT01877785
A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
- First Posted Date
- 2013-06-12
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01875705
- Locations
- 🇺🇸
Sarah Cannon Research Inst., Nashville, Tennessee, United States
🇫🇷Institut Gustave Roussy; Departement Oncologie Medicale, Villejuif, France
🇺🇸Karmanos Can Inst, Detroit, Michigan, United States